Biopharma R&D Varies Year to Date
Merck, Johnson & Johnson significantly increase R&D spending in first half of year
Tanya Samazan has written about the analytical and life science instrument industry for over 15 years. She has conducted hundreds of in-depth interviews with industry leaders and participants for IBO. She has written extensively about major companies, business trends, end-markets and technology developments, providing insight and analysis about industry prospects and developments. Her comments have also appeared in Chemical & Engineering News. Tanya is a graduate of UCLA and previously worked at the UCLA Law Review.
Merck, Johnson & Johnson significantly increase R&D spending in first half of year
Ortho Clinical Diagnostics emerges as big winner at IMV ServiceTrak Awards
Agilent, Bruker keeping busy with acquisitions in 2018
Lab instruments affected in US/China tariffs
Private sector now leading R&D funding, as federal funding continues decline
Acquisition provides Illumina with strong NGS data processing capabilities
IBO spotlights DKSH’s work across Asia
Axcend’s new HPLC product boasts portability, high-sensitivity
Nordic countries continue fostering life science sectors
JEOL, Anton Paar among companies to feature new products at Pittcon 2018
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
